COVID-19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange.
hematology
infectious diseases
pediatrics and adolescent medicine
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
03
09
2020
revised:
23
12
2020
accepted:
27
12
2020
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
27
3
2021
Statut:
epublish
Résumé
Patients with sickle cell disease are already at high risk for respiratory complications, which SARS-CoV-2 can rapidly worsen. The case emphasizes the importance of efficiently maximizing standard therapies in sickle cell patients with COVID-19.
Identifiants
pubmed: 33768846
doi: 10.1002/ccr3.3774
pii: CCR33774
pmc: PMC7981740
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1367-1370Subventions
Organisme : NIAID NIH HHS
ID : T32 AI095202
Pays : United States
Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors indicate they have no potential conflicts of interest to disclose.
Références
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Thromb J. 2018 Oct 4;16:27
pubmed: 30305805
BMJ. 2020 Jul 3;370:m2648
pubmed: 32620554
Am J Hematol. 2020 Jul;95(7):E154-E156
pubmed: 32243621
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Br J Haematol. 2020 Jul;190(1):e21-e24
pubmed: 32420608
Br J Haematol. 2020 Jul;190(2):e86-e89
pubmed: 32445595
J Natl Med Assoc. 2008 Aug;100(8):948-951
pubmed: 28643632
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Br J Haematol. 2020 Aug;190(4):e221-e224
pubmed: 32652551
N Engl J Med. 1994 Mar 17;330(11):733-7
pubmed: 8107739